Skip to main content
. Author manuscript; available in PMC: 2024 Mar 18.
Published in final edited form as: J Vasc Surg. 2020 May 19;73(2):608–625. doi: 10.1016/j.jvs.2020.04.498

Table 4.

Associations of clinical characteristics with change in six-minute walk among participants randomized to exercise and control, respectively (continued)

N Baseline six-minute walk, mean (STD) 6-month six-minute walk, mean (STD) Change of six-minute walk within group, mean (95% CI) Change of six-minute walk between groups, mean (95% CI) P value
Diabetes
Participants randomized to exercise
No 90 344.64 (95.69) 369.88 (90.96) 25.24 (12.53, 37.95) Reference 0.7043
Yes 51 323.48 (94.98) 352.78 (86.08) 29.30 (12.42, 46.19) 4.07 (−17.07, 25.20)
Participants randomized to control
No 87 345.48 (91.75) 340.77 (103.27) −4.71 (−17.57, 8.16) Reference 0.3414
Yes 55 320.69 (92.66) 306.01 (95.05) −14.69 (−30.86, 1.49) −9.98 (−30.65, 10.69)
Coronary artery disease
Participants randomized to exercise
No 97 348.03 (95.13) 377.05 (80.97) 29.02 (16.79, 41.25) Reference 0.5042
Yes 44 312.65 (93.27) 334.25 (100.18) 21.61 (3.45, 37.77) −7.42 (−29.31, 14.48)
Participants randomized to control
No 106 338.60 (91.89) 327.44 (101.38) −11.15 (−22.81, 0.51) Reference 0.3858
Yes 36 327.86 (95.40) 326.90 (102.35) −0.97 (−20.97, 19.04) 10.19 (−12.97, 33.35)
Pulmonary disease
Participants randomized to exercise
No 128 340.13 (94.78) 364.15 (88.77) 24.02 (13.46, 34.59) Reference 0.1003
Yes 13 306.07 (102.45) 359.20 (98.00) 53.13 (19.99, 86.27) 29.10 (−5.68, 63.89)
Participants randomized to control
No 122 339.19 (95.47) 329.47 (105.63) −9.72 (−20.68, 1.23) Reference 0.6458
Yes 18 315.01 (73.40) 312.40 (72.68) −2.61 (−31.12, 25.91) 7.12 (−23.43, 37.66)
Heart failure
Participants randomized to exercise
No 129 336.88 (95.07) 364.46 (89.73) 27.58 (16.98, 38.18) Reference 0.2952
Yes 10 364.54 (95.46) 371.12 (86.85) 6.58 (−31.49, 44.65) −21.00 (−60.52, 18.52)
Participants randomized to control
No 122 340.26 (94.36) 328.99 (104.40) −11.27 (−22.10, −0.44) Reference 0.1910
Yes 20 309.11 (77.51) 317.02 (80.93) 7.91 (−18.84, 34.66) 19.18 (−9.68, 48.04)
Symptoms of classic intermittent claudication
Participants randomized to exercise
No 90 335.65 (96.76) 364.28 (87.69) 28.63 (15.92, 41.34) Reference 0.6196
Yes 51 339.34 (94.54) 362.66 (92.94) 23.31 (6.43, 40.19) −5.32 (−26.45, 15.81)
Participants randomized to control
No 98 337.71 (95.71) 327.62 (105.07) −10.09 (−22.24, 2.06) Reference 0.6584
Yes 44 331.80 (86.08) 326.61 (93.38) −5.20 (−23.33, 12.94) 4.89 (−16.94, 26.72)
Asymptomatic (no exertional leg symptoms)
Participants randomized to exercise
No 133 333.81 (94.36) 361.64 (88.79) 27.83 (17.40, 38.26) Reference 0.3741
Yes 8 389.72 (108.00) 397.80 (96.95) 8.08 (−34.46, 50.62) −19.75 (−63.55, 24.05)
Participants randomized to control
No 136 334.68 (93.15) 326.90 (102.42) −7.78 (−18.08, 2.52) Reference 0.4597
Yes 6 362.97 (80.33) 336.40 (76.34) −26.57 (−75.61, 22.47) −18.79 (−68.90, 31.32)